Agilent Technologies Inc. (NYSE: A) today reported orders of $1.69 billion, down 8 percent compared with one year ago, and revenues of $1.73 billion for the second fiscal quarter ended April 30, 2013, flat with one year ago. Second-quarter GAAP net income was $166 million, or $0.48 per share. Last year’s second-quarter GAAP net income […]
ALAMEDA, Calif. & JERUSALEM — BioTime, Inc. (NYSE MKT: BTX) and its subsidiary Cell Cure Neurosciences Ltd. (Cell Cure Neurosciences) today announced that Cell Cure Neurosciences has been awarded a grant of 5.34 million Shekels, approximately $1.5 million, for 2013 from Israel’s Office of the Chief Scientist (OCS) to help finance the development of OpRegen®, […]
ALAMEDA, Calif.– BioTime, Inc. (NYSE MKT: BTX), a biotechnology company that develops and markets products in the field of regenerative medicine, today reported financial results for the first quarter ended March 31, 2013 and highlighted recent corporate accomplishments. First Quarter and Recent Corporate Accomplishments Entered into an Asset Contribution Agreement with Geron Corporation (“Geron”) and […]
San Francisco Bay Area, CA — Real Time Genomics, Inc., the genome analytics company, today announced that it had secured a $5mm investment to fund the expansion of commercial operations. The company also disclosed that two leading genome research centers at Stanford University have purchased the company’s genome analysis platform. Researchers at the Center for […]
Omaha, Neb.- Transgenomic, Inc. (OTC/BB: TBIO) today reported financial results for the first quarter ended March 31, 2013 and provided a business update. First Quarter Financial Results Net sales for the first quarter of 2013 increased by $0.2 million, or 2%, to $7.4 million compared to $7.2 million for the same period in 2012. The […]
ST. LOUIS — Sigma-Aldrich Corporation (NASDAQ: SIAL), a leading Life Science and High Technology company (the “Company”), announced today at its 2013 Annual Shareholders Meeting that the Company’s Board of Directors approved a quarterly cash dividend of $0.215 per share. The dividend is payable on June 14, 2013 to shareholders of record on May 31, […]
BERGISCH GLADBACH, Germany–RI Research Instruments GmbH, a majority-owned subsidiary of Bruker Energy & Supercon Technologies, Inc. (BEST), today announced the award of an option valued at approximately $7.3 million, for an additional 120 superconducting radio-frequency (rf) cavities, on top of its on-going 300-cavity contract for the European XFEL, a new international research facility near Hamburg, […]
CAMBRIDGE, Mass.–Firefly BioWorks announced today the awarding of three Firefly Frontiers Grants to leading researchers engaged in pushing the boundaries of microRNA research. The Frontiers Grant, a $10,000 award to be used on the company’s products, is designed to help scientists scale microRNA research from discovery to validation. Three of the Frontiers Grant winners are: […]
Hercules, CA —— Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a multinational manufacturer and distributor of life science research and clinical diagnostic products, announced financial results today for the first quarter ended March 31, 2013. First-quarter reported revenues were $499.7 million, up 2.8% compared to $486.3 million reported for the first quarter of 2012. These […]
Albuquerque, New Mexico — IntelliCyt Corporation, a leading provider of assay screening solutions for phenotypic drug discovery, antibody discovery and in vitro toxicity testing, today announced it has completed an $8 million financing round. The financing was led by new investor Arboretum Ventures with participation from existing investors Prolog Ventures, Verge Fund, and New Mexico […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
